just a little snippet they slipped in
using nasal anterior samples, Eugeni achieved a sensisitivty of 96.7%. using samples from ct15- ct30. these were from direct patient samples and we only missed 1 out of 30.
what will our Eugeni test provide with nasal pharyngeal samples (without VIDRL VTM interference) ? which from the last presentation is more accurate. if it doesn't miss that 1 positive it would be 30 out of 30. what % would that be??? come on TGA....
ps. hopefully the quarterly was released a day earlier than usual to free up tomorrow...
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-57
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $28.14K | 1.340M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 579636 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 628168 | 6 |
View Market Depth
| Last trade - 15.24pm 08/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |